UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000010763
Receipt number R000012583
Scientific Title Emergence agitation in pediatric patients after sevoflurane anesthesia without nitrous oxide or combination with nitrous oxide
Date of disclosure of the study information 2013/05/20
Last modified on 2014/04/28 10:04:54

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Emergence agitation in pediatric patients after sevoflurane anesthesia without nitrous oxide or combination with nitrous oxide

Acronym

emergence agitation after sevoflurane without nitrous oxude

Scientific Title

Emergence agitation in pediatric patients after sevoflurane anesthesia without nitrous oxide or combination with nitrous oxide

Scientific Title:Acronym

emergence agitation after sevoflurane without nitrous oxude

Region

Asia(except Japan)


Condition

Condition

tonsillectomy and adenoidectomy surgery

Classification by specialty

Pediatrics Anesthesiology Child

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

compare the emergence agitation, recovery time of children assigned to receive sevoflurane (group S) or sevoflurane with N2O (group N)

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Anesthetic maintenance using sevoflurane without nitrous oxide is associated with a higher end tidal concentration of sevoflurane at emergence than sevoflurane with nitrous oxide; however, this difference may be dose-related. The anesthetic properties of these two maintenance methods do not seem to have a role in the incidence of emergence delirium or recovery profile.

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Behavior,custom

Interventions/Control_1

anesthesia was maintained with sevoflurane alone in the group S

Interventions/Control_2

anesthesia was maintained with 50% N2O and sevoflurane in the group N

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

3 years-old <=

Age-upper limit

10 years-old >=

Gender

Male and Female

Key inclusion criteria

patients scheduled for elective surgery of tonsillectomy and adenoidectomy

Key exclusion criteria

Patients with a history of cardiovascular, respiratory (asthma), neurologic (seizure), kidney, liver disease, mood disorder, prematurity, or developmental delay, the presence of upper respiratory infection, hypersensitivity to drugs, and those receiving analgesics, sedatives or psychiatric medication were excluded.

Target sample size

42


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Il-Ok Lee

Organization

Korea University

Division name

Anesthesiology and Pain Medicine

Zip code


Address

Gurodong-ro 148, Guro-gu, Seoul, Republic of Korea

TEL

82-2-2626-3234

Email

iloklee@korea.ac.kr


Public contact

Name of contact person

1st name
Middle name
Last name Il-Ok Lee

Organization

Korea University

Division name

Anesthesiology and Pain Medicine

Zip code


Address

gurodong-ro 148, guro-gu, Seoul, Republic of Korea

TEL

82-2-2626-3234

Homepage URL


Email

iloklee@korea.ac.kr


Sponsor or person

Institute

Korea University

Institute

Department

Personal name



Funding Source

Organization

Korea University

Organization

Division

Category of Funding Organization

Outside Japan

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2013 Year 05 Month 20 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2013 Year 05 Month 20 Day

Date of IRB


Anticipated trial start date

2013 Year 05 Month 20 Day

Last follow-up date

2013 Year 11 Month 22 Day

Date of closure to data entry

2013 Year 11 Month 22 Day

Date trial data considered complete

2013 Year 11 Month 22 Day

Date analysis concluded

2013 Year 11 Month 27 Day


Other

Other related information



Management information

Registered date

2013 Year 05 Month 20 Day

Last modified on

2014 Year 04 Month 28 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000012583


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name